Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
daydreaming2's Profile
Displaying 251-300 of 1368 result(s).
IPIX Innovation Pharmaceuticals Inc
04/20/2017 4:54:16 PM
Don't be surprised for tomorrow reb
IPIX Innovation Pharmaceuticals Inc
04/20/2017 4:23:02 PM
Closed at 0.85 There were 2 T trade (1)
IPIX Innovation Pharmaceuticals Inc
04/20/2017 3:52:42 PM
They were ready and hoping for this (2)
IPIX Innovation Pharmaceuticals Inc
04/20/2017 2:57:39 PM
I am with you on this one. It was f (1)
IPIX Innovation Pharmaceuticals Inc
04/19/2017 11:04:08 PM
Just remember when it comes to the (1)
IPIX Innovation Pharmaceuticals Inc
04/18/2017 10:20:40 PM
Wow 2 days of of nervous short mani (2)
IPIX Innovation Pharmaceuticals Inc
04/18/2017 11:03:36 AM
That really shows the MMs are in he
IPIX Innovation Pharmaceuticals Inc
04/17/2017 2:43:22 PM
The attacks on Cellceutix are movin (1)
IPIX Innovation Pharmaceuticals Inc
04/17/2017 10:57:28 AM
I don't think big pharma can ignore
IPIX Innovation Pharmaceuticals Inc
04/13/2017 8:55:36 AM
CDEL (Citadel securities) uses the (5)
IPIX Innovation Pharmaceuticals Inc
04/12/2017 12:56:39 PM
CDEL has been signal he needs share
IPIX Innovation Pharmaceuticals Inc
04/11/2017 2:56:30 PM
Afternoon fake block to keep under (1)
IPIX Innovation Pharmaceuticals Inc
04/11/2017 10:09:58 AM
Manipulation? Green is a buy at the
IPIX Innovation Pharmaceuticals Inc
04/11/2017 8:26:03 AM
Hey if we are going to speculate on
IPIX Innovation Pharmaceuticals Inc
04/10/2017 9:16:00 AM
Of course the manipulating MMs CSTI
IPIX Innovation Pharmaceuticals Inc
04/06/2017 11:50:05 PM
You can bet someone's pay check is (2)
IPIX Innovation Pharmaceuticals Inc
04/04/2017 10:45:49 AM
CDEL seeking himself 66k skates loo
IPIX Innovation Pharmaceuticals Inc
04/04/2017 10:25:11 AM
Seems as though the manipulators ar (1)
IPIX Innovation Pharmaceuticals Inc
04/03/2017 4:10:24 PM
Somebody's pay check is dependent o (1)
IPIX Innovation Pharmaceuticals Inc
04/03/2017 11:09:14 AM
Mostly CDEL selling to themselves.. (1)
IPIX Innovation Pharmaceuticals Inc
04/03/2017 11:04:18 AM
They are trying extremely hard to k (1)
IPIX Innovation Pharmaceuticals Inc
04/03/2017 10:48:54 AM
Bid and Ask 1.01 for over an minute (1)
IPIX Innovation Pharmaceuticals Inc
03/30/2017 9:43:22 AM
There's the fake take down to look
IPIX Innovation Pharmaceuticals Inc
03/30/2017 8:55:12 AM
Oh imagine that bashers and non-inv
IPIX Innovation Pharmaceuticals Inc
03/29/2017 7:50:25 PM
Not to mention she has a connection
IPIX Innovation Pharmaceuticals Inc
03/29/2017 7:40:32 PM
The judges reasoning... she is an i
IPIX Innovation Pharmaceuticals Inc
03/29/2017 5:21:39 PM
3 investors $2mil is a hefty invest
IPIX Innovation Pharmaceuticals Inc
03/29/2017 4:54:12 PM
Who are the investors?
IPIX Innovation Pharmaceuticals Inc
03/23/2017 1:11:05 PM
Shorts? I don't remember Egbert see
IPIX Innovation Pharmaceuticals Inc
03/21/2017 9:59:22 AM
A real investor/buyer can come in a
IPIX Innovation Pharmaceuticals Inc
03/20/2017 11:01:35 AM
Difference between bid and ask .. b (4)
IPIX Innovation Pharmaceuticals Inc
03/18/2017 9:05:06 AM
Adam Feuersteins.... failed hedge f (6)
IPIX Innovation Pharmaceuticals Inc
03/14/2017 8:17:50 AM
I like how the noretreat and turd t (4)
IPIX Innovation Pharmaceuticals Inc
03/13/2017 12:39:16 AM
MM ETRF was a subsidiary of etrade.
IPIX Innovation Pharmaceuticals Inc
03/09/2017 10:00:57 AM
CDEL very desperately trying to man (1)
IPIX Innovation Pharmaceuticals Inc
03/08/2017 2:46:14 PM
He just dug himself in now than 40k
IPIX Innovation Pharmaceuticals Inc
03/08/2017 2:34:57 PM
There it goes... $1... a quick 100 (1)
IPIX Innovation Pharmaceuticals Inc
03/08/2017 2:32:38 PM
Someone is buying up all CDELs shar
IPIX Innovation Pharmaceuticals Inc
03/08/2017 8:08:54 AM
This is a different presentation th
IPIX Innovation Pharmaceuticals Inc
03/07/2017 6:46:16 AM
MM Manipulation. Notice they closed (1)
IPIX Innovation Pharmaceuticals Inc
03/06/2017 8:53:36 PM
How did they do that same trading p (1)
IPIX Innovation Pharmaceuticals Inc
03/06/2017 3:32:41 PM
Bet you we have another 40% short d (1)
IPIX Innovation Pharmaceuticals Inc
03/01/2017 10:30:11 AM
Funny at the top of the article it
IPIX Innovation Pharmaceuticals Inc
03/01/2017 9:13:21 AM
Starting to see more articles about (1)
IPIX Innovation Pharmaceuticals Inc
02/27/2017 9:39:23 AM
A signal for help first thing in th (2)
IPIX Innovation Pharmaceuticals Inc
02/27/2017 9:33:08 AM
Cellceutix's is not sitting back to
IPIX Innovation Pharmaceuticals Inc
02/24/2017 4:11:26 PM
They just got fined again by SEC... (1)
IPIX Innovation Pharmaceuticals Inc
02/22/2017 8:24:55 AM
If I was part of the short and dist (3)
IPIX Innovation Pharmaceuticals Inc
02/21/2017 3:53:48 PM
CDEL had been buying a lot... selli
IPIX Innovation Pharmaceuticals Inc
02/17/2017 5:50:09 PM
Not as easy at it is to create mult
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >

Recent Articles

  • Axiado and Posiflex Group Launch Cutting-Edge AI Solution
  • Investors Urged to Join Class Action Against Rock Holdings, Inc.
  • Investor Alert: Legal Action Against West Pharmaceutical Services
  • West Pharmaceutical Services Faces Class Action Lawsuit for Investors
  • Empowering the Restaurant Experience for Future Success
  • XenDex Presale Ending Soon: Secure $XDX Tokens Now
  • XenDex's Final Presale Phase Sparks Interest Amid XRP Surge
  • XRT Token Soars 150% Amidst Ripple's Rising Surge
  • Bonside's Innovative Scorecard Revolutionizes Retail Underwriting
  • Kevin Hochman Honored with Gold Plate Award for Leadership
  • Nimanode Launches Revolutionary No-Code AI Platform on XRPL
  • Volvo Group Mourns the Loss of Chief Purchasing Officer Andrea Fuder
  • Canopy Growth Corporation Legal Challenge: Investors Unite
  • Cytokinetics Unveils New Insights on Aficamten's Impact at Congress
  • Investors Have Chance to Lead Class Action Against SVVC Fund
  • Mads Mikkelsen Introduces a Unique Negroni at Cannes Festival
  • Promising Two-Year Data Revealed for Nexiguran Ziclumeran Study
  • Innovative Advances in CMT-SORD: Applied Therapeutics Updates
  • Samaritan's Purse Mobilizes to Support Tornado-Affected Families
  • Bitcoin Solaris Introduces Groundbreaking Mining Technology
  • Connie Chan Takes the Helm as Chief Growth Officer at Stagwell
  • Exciting Travel Offers for Adventure Seekers Unveiled
  • HKPA and APTEC Unveil Innovative CTV Initiative at China Print
  • Empowering Young Leaders: Live Good's Revamped Initiative
  • Rescue Smokers Achieve Grand Champion Glory at SmokeSlam BBQ
  • JJ's Triumph at Eurovision 2025 Marks His Rise in Music
  • Exciting New Travelzoo Offers for Enthusiasts Awaiting You
  • Questlove's Inspiring Graduation Speech: A Journey of Growth
  • Dillard’s, Inc. Declares $0.25 Dividend for Shareholders
  • XenDex Presale Ramps Up Amid XRP Price Surge: Key Developments
  • Houston Boston Partnership Expands with New Automotive Allies
  • Tectonic Therapeutic's TX45 Shows Promise in Phase 1b Study
  • Unlocking the Power of Leverage in Crypto Trading with BexBack
  • Legal Action Against Walgreen Co. for Meal Break Violations
  • Investors Alert: Join the Class Action Against Sana Biotechnology
  • JAMining Unveils Innovative Cloud Mining for Top Altcoins
  • Artly's Barista Bot Revolutionizes Coffee Experience at NRA
  • Çelebi Aviation Addresses Current Airport Operations Update
  • Introducing the Bitcoin Solaris Developer API Suite
  • Highlights of Week 17: Progress Under Trump’s Leadership
  • TaskUs Shareholders Invited to Explore Legal Options Against Buyout
  • Exploring Skechers' Recent Merger and Shareholder Concerns
  • Legal Actions and Shareholder Rights: Ibotta Updates
  • Assessing Legal Options for Iovance Biotherapeutics Investors
  • Fractyl Health's Rejuva® Therapy Promises New Hope for Obesity
  • Malai Unveils New Ice Cream Shop in Philadelphia with Flavor
  • Destination XL Expands Presence with New Store Opening
  • Understanding the Art of Giving for a Change in Humanity
  • Çelebi Aviation's Commitment to ETHICS and Compliance
  • Arcadis Achieves Key Milestones with Shareholder Support and Dividend Approval
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site